Two separate studies have linked heart drugs Lipitor (used to treat high cholesterol) and Digoxin (prescribed to patients in cardiac failure or abnormal heart beats), the higher the risk of diabetes, and cancer in the breast milk.
According to the United States Census Bureau, Lipitor to the website of thepeople who have diabetes, it is recommended to consult their doctor before you begin (known generically Atorvastatin) Lipitor. In 2008, research, and coherent (and Digitek Lanoxin trade) with Digoxin increased risk of breast cancer.
Lipitor study, published in magazine, the American College of Cardiologyinvolved in the food service business of diabetes free adults who had a history of stroke or transient ischemic attacks ("mini" line).
One of the five-year Trial, compared to plasebon and after taking into account factors such as age, weight and smoking was associated with Atorvastatin 37% greater risk of developing diabetes.
But the other five years of trials, such as comparing Lipitor Zocor or higher dose Atorvastatin, smaller doses of drugs, the risk was much smaller; 6.4-5,6% and 9% to 8%, respectively. Researchers say the increase is due to the effect of Lipitor, the possibility to regulate the body's blood sugar.
Digoxin, which appeared in the research Journal of clinical onkologian, Denmark in the women's 100, 000 to analyze the data to researchers ages 20 and older who took Digoxin at some point during the 12 years. The results showed the possibility of developing breast cancer was the women of the highest level of taking Digoxin research during the first five years.
But these five years after the risk decreased. However, the higher risk people taking Digoxin was returned by at least three years. Other drugs, because usually in combination with Digoxin is not associated with breast cancer risk.
The importance of play in both studies, the researchers talking to your doctor before starting a new drug treatment program.
Image credit: the pink ice photography including the juice
No comments:
Post a Comment